Skip to main content

Science + Tech

MetroHealth forms its Center for Cancer Research, dedicated to delivering cutting-edge care to everyone
From MetroHealth: Bingcheng Wang, PhD (pictured), Director of the Division of Cancer Biology in the Department of Medicine and Director of Basic Sciences in the MetroHealth Research Institute, has assembled an impressive team of cancer researchers who are bringing cutting-edge care to The…
lung_cancer
Using artificial intelligence to prevent harm caused by immunotherapy
Researchers at Case Western Reserve University discover biomarkers to identify lung cancer patients who could be made worse by same drugs that helps many others Researchers at Case Western Reserve University, using artificial intelligence (AI) to analyze simple tissue scans, say they have…
Researchers to lead Northeast Ohio initiative to increase prostate cancer screening in African American men
African American men in Cuyahoga County have a 60% increased risk of being diagnosed with prostate cancer and an 80% increased risk of dying from prostate cancer compared to white men, according to data from the Case Comprehensive Cancer Center (Case CCC). With a new $2.75 million, three-year grant…
cancer-cells-feat
Case Comprehensive Cancer Center researchers to lead Northeast Ohio initiative to increase prostate cancer screening in African American men
Supported with three-year, $2.75M grant from Bristol Myers Squibb Foundation African American men in Cuyahoga County have a 60% increased risk of being diagnosed with prostate cancer and an 80% increased risk of dying from prostate cancer compared to white men, according to data from the Case…
Dean%20Carol%20Musil%20NURSING%20090919_135.jpg
Thank you and best wishes to Dr. de Lima
We thank Marcos de Lima, MD as he is headed off to The Ohio State University. He has had a very large impact as a program leader for our Hematopoietic and Immune Cell Biology Program and head of the Hematological Malignancies Division of UH Seidman Cancer Center. He helped promote cell and immune…
New method of counting tumor cells offers possibility of a “liquid biopsy”
From Cleveland Clinic Lerner Research Institute: In a new study published in the Journal of Chromatography A, Cleveland Clinic researchers, led by Aaron Fleischman, PhD and Maciej Zborowski, PhD, reveal findings from a new device they've developed to identify and perform differential counts of…
Ting, collaborators at Fred Hutchinson Cancer Research Center awarded $1M grant from W.M. Keck Foundation to study host-microbe epigenetic crosstalk
Please join us in congratulating Cleveland Clinic Lerner Research Institute's Angela Ting, PhD as she is co-leading a team of investigators at Fred Hutchinson Cancer Research Center and Cleveland Clinic who were recently awarded $1 million in medical research grant funding from the W.M. Keck…